文献速递腹部技术与安全MR

3D组织模型作为胰腺癌放疗筛选工具的研究综述

3d tissue models as tools for radiotherapy screening for pancreatic cancer.
PubMed 文献 · Br J Radiol · 2021-03-08

该综述汇总了用于胰腺导管腺癌(PDAC)放射反应研究的3D模型,指出2D培养和动物模型在复现肿瘤微环境(TME)方面的局限,强调3D模型能更好捕捉结构、生物物理、生物化学和生物力学特征,但该领域研究不足,尤其缺乏对PDAC复杂微环境的复现及统一的影像定量方法。

要点

  • 3D模型可复现PDAC肿瘤微环境的结构与力学特征,优于2D培养和动物模型。
  • PDAC放疗反应研究中3D模型应用仍属研究不足领域,缺乏统一影像定量方法。
  • MRI引导放疗和质子治疗等新技术需仿生平台评估其相对光子放疗的生物有效性。

临床应用与阅片要点

  • 阅片/报告时需注意:3D模型影像定量方法尚未统一,评估TME组分时缺乏公认标准。
  • 关注MRI引导放疗中静态磁场(SMF)对辐射生物效应的影响,原文指出该领域研究不足。
  • 质子治疗与光子放疗的生物有效性可能不同,需可靠仿生平台预测体内反应。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The efficiency of radiotherapy treatment regimes varies from tumour to tumour and from patient to patient but it is generally highly influenced by the tumour microenvironment (TME). The TME can be described as a heterogeneous composition of biological, biophysical, biomechanical and biochemical milieus that influence the tumour survival and its' response to treatment. Preclinical research faces challenges in the replication of these in vivo milieus for predictable treatment response studies. 2D cell culture is a traditional, simplistic and cost-effective approach to culture cells in vitro, however, the nature of the system fails to recapitulate important features of the TME such as structure, cell-cell and cell-matrix interactions. At the same time, the traditional use of animals (Xenografts) in cancer research allows realistic in vivo architecture, however foreign physiology, limited heterogeneity and reduced tumour mutation rates impairs relevance to humans. Furthermore, animal research is very time consuming and costly. Tissue engineering is advancing as a promising biomimetic approach, producing 3D models that capture structural, biophysical, biochemical and biomechanical features, therefore, facilitating more realistic treatment response studies for further clinical application. However, currently, the application of 3D models for radiation response studies is an understudied area of research, especially for pancreatic ductal adenocarcinoma (PDAC), a cancer with a notoriously complex microenvironment. At the same time, specific novel and/or more enhanced radiotherapy tumour-targeting techniques such as MRI-guided radiotherapy and proton therapy are emerging to more effectively target pancreatic cancer cells. However, these emerging technologies may have different biological effectiveness as compared to established photon-based radiotherapy. For example, for MRI-guided radiotherapy, the novel use of static magnetic fields (SMF) during radiation delivery is understudied and not fully understood. Thus, reliable biomimetic platforms to test new radiation delivery strategies are required to more accurately predict in vivo responses. Here, we aim to collate current 3D models for radiation response studies of PDAC, identifying the state of the art and outlines knowledge gaps. Overall, this review paper highlights the need for further research on the use of 3D models for pre-clinical radiotherapy screening including (i) 3D (re)-modeling of the PDAC hypoxic TME to allow for late effects of ionising radiation (ii) the screening of novel radiotherapy approaches and their combinations as well as (iii) a universally accepted 3D-model image quantification method for evaluating TME components in situ that would facilitate accurate post-treatment(s) quantitative comparisons.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Wishart G, Gupta P, Schettino G, et al. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. Br J Radiol. 2021. PMID: 33684308. doi:10.1259/bjr.20201397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。